Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Maze Therapeutics
Biotech
After FTC stalled Sanofi deal, Shionogi bags Maze's Pompe drug
Five months after the FTC scuttled Sanofi’s attempt to acquire Maze Therapeutics’ Pompe disease program, Japan’s Shionogi has scooped up the asset.
James Waldron
May 10, 2024 5:02am
Sanofi CEO does not rule out future Pompe BD despite FTC moves
Jan 10, 2024 3:37pm
Sanofi scraps Maze deal after FTC throws up antitrust obstacles
Dec 12, 2023 6:00am
Sanofi to enter Maze deal with $750M pact for Pompe med
May 1, 2023 6:00am
BIO CEO out the door—Chutes & Ladders
Oct 14, 2022 9:30am
Discovery of ALS and dementia mechanism points to new treatment
Feb 23, 2022 11:00am